Rare Kidney Diseases Market Is Driven By Rising Awareness

By Author: colin
Total Articles: 166
Comment this article

One of the key factors fueling the growth of the rare kidney diseases market is the increasing availability of diagnosis and treatment. Rare kidney diseases include conditions like focal segmental glomerulosclerosis (FSGS), IgA nephropathy, Alport syndrome, polycystic kidney disease, and Nephrotic syndrome. These conditions require specialized treatment approach such as targeted therapies, gene therapy or stem cell therapy. Conventional treatments including dialysis and kidney transplant provide symptomatic relief but do not cure the underlying condition. Rising awareness among patients and healthcare providers about new treatment options is resulting in early diagnosis and management of rare kidney diseases.

The Rare Kidney Diseases Market is estimated to be valued at US$ 3.9 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024-2031.

Key Takeaways

Key players operating in the rare kidney diseases are Seres Therapeutics, Inc.,Enterome,4D pharma plc,International Flavors & Fragrances Inc.,OptiBiotix Health Plc. Seres Therapeutics is developing microbiome therapies for treating ...
... resistant rare kidney disease conditions. Enterome focuses on developing pharmaceuticals from gut microbiome.

The demand for rare kidney disease treatment is increasing owing to rising patient pool, growing awareness, and availability of targeted therapies. According to data, about 12 million people worldwide are affected by rare kidney diseases. Most rare kidney diseases start in early childhood and require lifelong treatment and monitoring.

Major pharmaceutical companies are investing in research and collaborating with biotech firms to develop novel therapies for rare kidney conditions. Geographical expansion into emerging markets and focus on undiagnosed patient populations would further aid market growth in the coming years.

Market Drivers

One of the major drivers for rare kidney diseases market is the growing success of gene therapy and cell therapy in clinical trials. Gene therapy aims to introduce normal genes into cells and tissues to replace missing or mutated genes, thus correcting the underlying cause of disease. Cell therapy involves transplanting healthy stem cells from cord blood or bone marrow to replace damaged cells. Promising clinical results of such innovative therapeutic approaches would help address unmet needs and drive the rare kidney disease market growth over the forecast period.

Geopolitical Situation And Market Growth

The rare kidney diseases market is facing challenges due to the ongoing geopolitical tensions and conflicts across various regions. The trade restrictions and sanctions imposed by countries are disrupting supply chains and availability of key drugs and therapies. This is negatively impacting the research and development activities of pharmaceutical companies. The market was also affected in 2020 and 2021 due to the COVID-19 pandemic as resources were diverted to address the public health crisis. However, with global efforts to control the pandemic, the market is showing signs of recovery from 2022.

The companies need to diversify their supplier base and look for alternative manufacturing/sourcing locations to mitigate risks. Collaboration with local players can help gain better access to rare disease patient pools in restricted markets. The industry should also focus on developing affordable therapies through public-private partnerships. Telehealth and digital tools can help overcome barriers to diagnosis and care faced by rare disease patients in remote and less developed areas.

Geographical Regions With High Market Value

North America currently accounts for the largest share of the rare kidney diseases market in terms of value. This is attributed to rising healthcare spending, availability of advanced treatment options, and presence of major industry players in the US and Canada. Recent drug approvals are also boosting the regional market growth. Europe is another major region benefiting from increasing funding for rare disease research. On the other hand, the market is witnessing rapid expansion in Asian countries like China, due to growing medical infrastructure, rising disposable incomes, and expanding patient access to sophisticated treatments.

Fastest Growing Region

The rare kidney diseases market is projected to grow the fastest in Asia Pacific excluding Japan from 2024 to 2031. This is because the prevalence of renal diseases is surging in heavily populated developing nations like India and China. Their governments are also working to improve diagnosis rates through nationwide screening programs. Investments in healthcare facilities and pharmaceutical R&D are expanding treatment opportunities in the region. As a result, many global vendors are focusing on partnerships and new drug launches to capitalize on the high growth potential offered by the Asia Pacific market.

Get more insights on this topic:   https://colinwilson11.hashnode.dev/rare-kidney-diseases-market-set-for-rapid-growth-with-promising-therapies-says-future-market-insights

Author Bio:

Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights. (LinkedIn: www.linkedin.com/in/alice-mutum-3b247b137 )

What Are The Key Data Covered In This Rare Kidney Diseases Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Rare Kidney Diseases's growth between 2024 and 2031.

:- Accurate calculation of the size of the Rare Kidney Diseases and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- Rare Kidney Diseases Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Rare Kidney Diseases vendors

FAQ’s

Q.1 What are the main factors influencing the Rare Kidney Diseases?

Q.2 Which companies are the major sources in this industry?

Q.3 What are the market’s opportunities, risks, and general structure?

Q.4 Which of the top Rare Kidney Diseases companies compare in terms of sales, revenue, and prices?

Q.5 Which businesses serve as the Rare Kidney Diseases’s distributors, traders, and dealers?

Q.6 How are market types and applications and deals, revenue, and value explored?

Q.7 What does a business area’s assessment of agreements, income, and value implicate?

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it